NOVOCURE LTD (NVCR) Stock Balance Sheet
NASDAQ:NVCR • JE00BYSS4X48
Current stock price
11.45 USD
-0.16 (-1.38%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 7.40M | 11.85M | 9.96M | 9.70M | 3.10M | |||
| Cash Equivalents | 76.13M | 151.92M | 227.17M | 105.60M | 205.70M | |||
| Marketable Securities | 364.14M | 796.11M | 673.50M | 854.10M | 728.90M | |||
| Receivables | 115.40M | 98.75M | 71.85M | 106.00M | 110.60M | |||
| Inventories | 41.11M | 35.09M | 38.15M | 29.40M | 24.40M | |||
| Other Current Assets | 42.55M | 12.87M | 13.79M | 6.70M | 800.00K | |||
| Total Current Assets | 646.73M | 1.11B | 1.03B | 1.11B | 1.07B | |||
| Non-Current Assets | ||||||||
| PPE Net | 147.00M | 119.59M | 97.70M | 69.00M | 53.90M | |||
| Other Non-Current Assets | 10.60M | 14.62M | 14.02M | 11.20M | 12.10M | |||
| Total Non-Current Assets | 157.59M | 134.21M | 111.72M | 80.10M | 66.00M | |||
| TOTAL ASSETS | 804.33M | 1.24B | 1.15B | 1.19B | 1.14B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 558.16M | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 76.02M | 56.08M | 59.27M | 46.60M | 46.30M | |||
| Accounts Payable | 122.23M | 105.09M | 94.39M | 85.20M | 72.60M | |||
| Other Current Liabilities | 24.97M | 37.05M | 25.46M | 27.00M | 23.70M | |||
| Total Current Liabilities | 223.23M | 756.38M | 179.12M | 158.80M | 142.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 195.05M | 97.30M | 568.82M | 565.50M | 562.20M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 45.59M | 26.93M | 35.70M | 26.20M | 24.20M | |||
| Total Non-Current Liabilities | 240.63M | 124.23M | 604.52M | 591.70M | 586.40M | |||
| TOTAL LIABILITIES | 463.86M | 880.61M | 783.63M | 750.50M | 729.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.29B | -1.15B | -985.50M | -778.50M | -685.90M | |||
| Additional Paid In Capital | 1.63B | 1.52B | 1.35B | 1.22B | 1.10B | |||
| Common Shares | 0.00 | 0.00 | N/A | N/A | 0.00 | |||
| Other Shareholders' Equity | -3.44M | -5.50M | -5.47M | -2.40M | -3.20M | |||
| Shares Outstanding | 112.49M | 108.52M | 107.08M | 105.00M | 104.00M | |||
| Tangible Book Value per Share | 3.03 | 3.32 | 3.39 | 4.20 | 3.95 | |||
| Total Shareholders' Equity | 340.47M | 360.18M | 362.50M | 441.20M | 410.50M | |||
| TOTAL LIABILITIES AND EQUITY | 804.33M | 1.24B | 1.15B | 1.19B | 1.14B | |||
| Statistics | ||||||||
| Debt/Equity | 0.57 | 1.82 | 1.57 | 1.28 | 1.37 | |||
| Current Ratio | 2.90 | 1.46 | 5.78 | 7.00 | 7.53 | |||
| Return On Assets (ROA) | -16.94% | -13.59% | -18.06% | -7.76% | -5.13% | |||
| Return On Equity (ROE) | -40.01% | -46.82% | -57.12% | -20.97% | -14.23% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21